GLP-1 Drugs Redefining Weight Loss | Oakland News

GLP-1 drugs like Ozempic and Wegovy are revolutionizing weight loss and chronic disease prevention, with usage skyrocketing from 3% to 11% of adults in just two years—and 15% of Americans having tried them. Awareness has surged to 91%, mirroring a drop in national obesity rates from nearly 40% to 36.4%, while diabetes diagnoses remain steady. Most users opt for brand-name versions, but 19% choose more affordable compounded alternatives, highlighting growing access. These meds work by regulating blood sugar and curbing appetite—making a real dent in public health as their impact continues to unfold. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a6749aeaf3b6079d